EORI-Search.co.uk

EORI-Search in


All Information about:

                        
Name

Clinical Solutions Acquisition Limited

Address
1 More London Place
London
SE1 2AF
VAT ID no VAT ID available
Company No. 05353896 Show on Companies House
Accountsdormant
last accounts made up to 31 December 2021
Sector (SIC)70100 - Activities of head offices
Company Register Statusliquidation
Previous Names
  • CAS Services Acquisition Limited
  • De Facto 1200 Limited
  • KYC Check
    KYC / PEP / AML request
    This data is incorrect?
    Sources: Company Register: Companies House (companieshouse.gov.uk)

    Quick access

    Persons with Significant Control (1)

    Source: Companies House
    gb-flag GB Clinical Solutions Finance Limited Status: Active Notified: 06/04/2016 Companies House Number: 05337592 Nature of Control
  • Ownership of shares - 75% or more
  • Ownership of voting rights - 75% or more
  • Right to appoint and remove directors
  • Officers (5)

    Source: Companies House
    Brownell, Elizabeth Helen London Status: Active Notified: 03/05/2023 Date of Birth: 07/1985 Occupation: Director Role: Director Country of Residence: England Nationality: British
    Capita Corporate Director Limited, London, England Status: Active Notified: 29/05/2012 Role: Director Nationality: Other
    Capita Group Secretary Limited, 65 Gresham Street, London, England, EC2V 7NQ Status: Active Notified: 29/05/2012 Role: Secretary Nationality: Other
    Baker, Christopher Francis Henry London, England Status: Ceased Notified: 14/11/2016 Ceased: 28/05/2021 Occupation: Director Role: Director Country of Residence: England Nationality: British
    Radford, Jamie Leigh London, United Kingdom Status: Ceased Notified: 03/09/2015 Ceased: 01/09/2016 Occupation: Director Role: Director Country of Residence: United Kingdom Nationality: British

    Companies Controlled by This Company (1)

    gb-flag GB Clinical Solutions International Limited Status: Active Notified: 06/04/2016 Companies House Number: 04394761 Nature of Control
  • Ownership of shares - 75% or more
  • Ownership of voting rights - 75% or more
  • Right to appoint and remove directors